Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2019, Article ID 9650184, 5 pages
https://doi.org/10.1155/2019/9650184
Case Series

Novel SUFU Frameshift Variant Leading to Meningioma in Three Generations in a Family with Gorlin Syndrome

1Department of Plastic Surgery, Hospital South West Jutland, Esbjerg, Denmark
2Department of Dermatology and Allergy, Gentofte Hospital and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
3Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4Department of Plastic Surgery and Burns Treatment, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
5Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Correspondence should be addressed to Gustav Askaner; moc.liamg@renaksag

Received 1 May 2019; Revised 13 June 2019; Accepted 1 July 2019; Published 28 July 2019

Academic Editor: Christos Yapijakis

Copyright © 2019 Gustav Askaner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. G. Evans, E. Howard, C. Giblin et al., “Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service,” American Journal of Medical Genetics Part A, vol. 152, no. 2, pp. 327–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Gorlin and R. W. Goltz, “Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome,” The New England Journal of Medicine, vol. 262, pp. 908–912, 1960. View at Publisher · View at Google Scholar · View at Scopus
  3. D. G. Evans and A. F. Peter, “Nevoid basal cell carcinoma syndrome,” in GeneReviews® [Internet], M. P. Adam, H. H. Ardinger, R. A. Pagon et al., Eds., University of Washington, Seattle, WA, USA, 2002. View at Google Scholar
  4. D. G. Evans, D. Oudit, M. J. Smith et al., “First evidence of genotype–phenotype correlations in Gorlin syndrome,” Journal of Medical Genetics, vol. 54, no. 8, pp. 530–536, 2017. View at Publisher · View at Google Scholar
  5. K. Fujii, H. Ohashi, M. Suzuki et al., “Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome,” Familial Cancer, vol. 12, no. 4, pp. 611–614, 2013. View at Publisher · View at Google Scholar
  6. E. A. Jones, M. I. Sajid, A. Shenton et al., “Basal cell carcinomas in gorlin syndrome: a review of 202 patients,” Journal of Skin Cancer, vol. 2011, pp. 1–6, 2010. View at Google Scholar
  7. A. J. Huq, M. Bogwitz, A. Gorelik, I. M. Winship, S. M. White, and A. H. Trainer, “Cohort study of Gorlin syndrome with emphasis on standardised phenotyping and quality of life assessment,” Internal Medicine Journal, vol. 47, no. 6, pp. 664–673, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Huq, M. Walsh, B. Rajagopalan et al., “Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same,” Familial Cancer, vol. 17, no. 4, pp. 601–606, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Smith, C. Beetz, S. G. Williams et al., “Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations,” Journal of Clinical Oncology, vol. 32, pp. 4155–4161, 2014. View at Google Scholar
  10. S. Onodera, A. Saito, D. Hasegawa et al., “Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype,” PLoS ONE, vol. 12, no. 9, Article ID e0184702, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. Taylor, L. Liu, C. Raffel et al., “Mutations in SUFU predispose to medulloblastoma,” Nat Genet, vol. 31, pp. 306–310, 2002. View at Google Scholar
  12. L. Brugieres, A. Remenieras, G. Pierron et al., “High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age,” Journal of Clinical Oncology, vol. 30, no. 17, pp. 2087–2093, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Choudry, H. C. Patel, N. T. Gurusinghe et al., “Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: Implications for treatment and surveillance,” Child's Nervous System, vol. 23, pp. 133–136, 2007. View at Google Scholar
  14. J. P. Neglia, L. L. Robison, M. Stovall et al., “New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the childhood cancer survivor study,” Journal of the National Cancer Institute, vol. 98, pp. 1528–1537, 2006. View at Google Scholar
  15. E. M. Thompson, T. Hielscher, E. Bouffet et al., “Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis,” Lancet Oncology, vol. 17, pp. 484–495, 2016. View at Google Scholar
  16. J. Rockhill, M. Mrugala, and M. C. Chamberlain, “Intracranial meningiomas: an overview of diagnosis and treatment,” Neurosurgical Focus, vol. 23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Aavikko, S. P. Li, S. Saarinen et al., “Loss of SUFU function in familial multiple meningioma,” American Journal of Human Genetics, vol. 91, pp. 520–526, 2012. View at Google Scholar
  18. C. Kijima, T. Miyashita, M. Suzuki, H. Oka, and K. Fujii, “Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation,” Familial Cancer, vol. 11, no. 4, pp. 565–570, 2012. View at Publisher · View at Google Scholar · View at Scopus